Joseah Bio   Report issue

For profit Phase 1
Founded: Seoul Korea, Republic of (2020)

Organization Overview

First Clinical Trial
2020
NCT04294875
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Joseah Bio

Active Ingredients

Drugs in Phase 1 Trials (1)

mpt0b640 (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infections (Phase 1)

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 1